Results 1 to 10 of about 27,602 (209)

Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin

Blood, 2008
Abstract Introduction: Earlier this year, heparin was found to be contaminated with a non-heparin sulfated polymer identified as oversulfated chondroitin sulfate (OSCS). The presence of this contaminant was associated with severe adverse reactions such as hypotension and anaphylaxis, leading to death in some patients.
Jacqueline Kuziej, Walter Jeske, Debra Hoppensteadt, Evangelos Litinas, Elizabeth McGeehan, Jawed Fareed, Richard H. Kennedy   +6 more
openaire   +1 more source

A complication of enoxaparin injection [PDF]

Cleveland Clinic Journal of Medicine, 2019
Computed tomography revealed a hematoma measuring 15 by 15 cm compressing the bladder and causing hydronephrosis.
Ahmad Muneer, Sharayah, Samrah, Zaigham, Noor, Hajjaj, Mihir, Maniar   +3 more
openaire   +2 more sources

Enoxaparin-induced hepatotoxicity: an under-recognised complication of enoxaparin therapy [PDF]

BMJ Case Reports, 2016
Low-molecular-weight heparins including enoxaparin are commonly used for anticoagulation as prophylaxis and treatment for deep vein thrombosis (DVT). Prescribers of enoxaparin monitor for common side effects, such as bleeding and thrombocytopenia, but hepatotoxicity, a less common and under-reported adverse effect, may be overlooked.
Katie Ann, Pivarnik, Fred, Schiffman, James, Sullivan, Arkadiy, Finn   +3 more
openaire   +2 more sources

Comparative Studies on Branded Enoxaparin and a US Generic Version of Enoxaparin

Clinical and Applied Thrombosis/Hemostasis, 2012
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of clinical indications. This study was carried out to compare the potency profile and pharmacodynamic responses of branded enoxaparin (Lovenox; Sanofi, US) with a generic enoxaparin (enoxaparin sodium injection, USP).
Jeanine M, Walenga, Walter P, Jeske, Debra, Hoppensteadt, Josephine, Cunanan, Hussein, Khan, Vicki, Escalante, Jawed, Fareed, Mamdouh, Bakhos   +7 more
openaire   +2 more sources

Enoxaparin-sodium [PDF]

Reactions Weekly, 2021
  +5 more sources

Enoxaparin [PDF]

, 2020
openaire   +1 more source

Optimizing Venous Thromboembolism Prophylaxis in Burn Patients Using Enoxaparin Through PBPK Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Mim SR, Yellepeddi VK, Azeredo FJ.
europepmc   +1 more source

Enoxaparin Dosing and Target anti-Factor Xa Achievement in Infants by Postmenstrual Age. [PDF]

J Pediatr Pharmacol Ther
Perez D, Mathew K.
europepmc   +1 more source

Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis. [PDF]

Res Pract Thromb Haemost
Ageno W, Arcelus JI, Stroh C, Djoudi Y, Abdel-Moneim M, Khan I, Ponomareva E, Carrier M.   +7 more
europepmc   +1 more source

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin. [PDF]

Cancers (Basel)
Baghdadi MA, do Carmo Las Casas PHF, Mbemba E, Rousseau A, Kempaiah P, Svistunov AA, Bitsadze V, Sabbah M, Fareed J, Van Dreden P, Trachana V, Lefkou E, Gerotziafas G.   +12 more
europepmc   +1 more source